XPEL, Inc. (XPEL)

NASDAQConsumer DiscretionaryAuto - PartsSnapshot 2026-10-23

$43.14-2.42%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge XPEL, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$137M–$139M	—
FY 2026 · Q4
Revenue	—	132.83M
EPS	—	0.557
FY 2026 · Annual
Revenue	—	531.95M
EPS	—	2.2
FY 2027 · Annual
Revenue	—

What the Thesis Depends On

5 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Expand manufacturing capacity in China	A supporting condition in XPEL, Inc.'s published investment case. The stated target is On track with expansion plans.	Intact	Expansion plans delayed or scaled back	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 of last 4 quarters. China revenue grew from $8.1M in 2025-Q1 to $11.7M in 2026-Q1 (+44.4%) and then to $15.9M in 2026-Q2 (+106.7% vs 2025-Q2). Management has consistently emphasized expanding manufacturing capacity in China, and the revenue growth trajectory matches this priority, indicating delivery.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	Unavailable	3 / 3
2026-07-25	Unavailable	Unavailable	3 / 3
2026-07-26	Unavailable	Unavailable	3 / 3
2026-07-27	Unavailable	Unavailable	3 / 3
2026-07-28	Unavailable	Unavailable	3 / 3
2026-07-29	Unavailable	Unavailable

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Expand manufacturing capacity in ChinaQualitative condition
Gross margin stays above 52% by FY2028Gross margin: 44.14%
Operating margin stays above 20% by FY2028Operating margin: 16.23%
Revenue grows to about $124 million in FY2025Revenue: $143.053M

Next proof point

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.3%Typical daily move · historical

Downside history

-31.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

XPEL, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

XPEL is a growth business whose thesis depends on continued revenue expansion and delivery on capacity plans. The long-term thesis is intact, with recent performance strong, but confidence is medium and earnings quality is fragile.

What's priced into XPEL, Inc.

The valuation is expensive versus peers, with a durable premium and a sizable expectations gap. The evidence flags this premium as unjustified given weak execution quality, so continued growth and reliable delivery matter to the market’s assumptions.

What the fundamentals likely do

Near-term results show revenue growth, while China revenue has expanded as management pursued added manufacturing capacity. The San Antonio facility acquisition is progressing, though the sharp rise in assets and liabilities points to ongoing integration; a guidance cut remains a meaningful risk.

What XPEL, Inc. hinges on

Over the next few quarters, the thesis hinges on maintaining revenue growth, expanding China capacity, and integrating the San Antonio facility without weakening execution. Sector bellwethers’ earnings and guidance may also signal whether the current sector tailwind persists or fades.

Bottom line

For the 1-3 year view, XPEL has a growing business and an intact thesis, but its expensive valuation leaves little room for weak execution, especially if guidance is cut. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.

EPS	—	2.843

2026-07-30	Unavailable	Unavailable	3 / 3

2026-07-31	Unavailable	Unavailable	3 / 3

2026-08-01	Unavailable	Unavailable	2 / 2

2026-08-02	Unavailable	Unavailable	3 / 3

2026-08-03	Unavailable	Unavailable	2 / 2

2026-08-04	Unavailable	Unavailable	2 / 2

2026-08-05	Unavailable	Unavailable	3 / 3

2026-08-06	Unavailable	Unavailable	2 / 2

2026-08-08	Unavailable	Unavailable	2 / 2

2026-08-09	Unavailable	Unavailable	2 / 2

2026-08-10	Unavailable	Unavailable	1 / 3

2026-08-12	Unavailable	Unavailable	2 / 2

2026-08-13	Unavailable	Unavailable	2 / 2

2026-08-14	Unavailable	Unavailable	2 / 2

2026-08-15	Unavailable	Unavailable	2 / 2

2026-08-16	Unavailable	Unavailable	1 / 2

2026-08-17	Unavailable	Unavailable	1 / 2

2026-08-18	Unavailable	Unavailable	1 / 2

2026-08-19	Unavailable	Unavailable	1 / 2

2026-08-20	Unavailable	Unavailable	1 / 2

2026-08-21	Unavailable	Unavailable	1 / 2

2026-08-22	Unavailable	Unavailable	1 / 2

2026-08-23	Unavailable	Unavailable	1 / 2

2026-08-24	Unavailable	Unavailable	1 / 2

2026-08-25	Unavailable	Unavailable	1 / 2

2026-08-26	Unavailable	Unavailable	1 / 2

2026-08-27	Unavailable	Unavailable	1 / 2

2026-08-28	Unavailable	Unavailable	1 / 2

2026-08-29	Unavailable	Unavailable	1 / 2

2026-08-30	Unavailable	Unavailable	1 / 2

2026-08-31	Unavailable	Unavailable	1 / 2

2026-09-01	Unavailable	Unavailable	1 / 2

2026-09-02	Unavailable	Unavailable	1 / 2

2026-09-03	Unavailable	Unavailable	1 / 2

2026-09-04	Unavailable	Unavailable	1 / 2

2026-09-05	Unavailable	Unavailable	1 / 2

2026-09-06	Unavailable	Unavailable	1 / 2

2026-09-07	Unavailable	Unavailable	1 / 2

2026-09-08	Unavailable	Unavailable	1 / 2

2026-09-09	Unavailable	Unavailable	1 / 2

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	3	1
2026-06-01	2	1
2026-07-01	2	1
2026-08-01	3	1
2026-09-01	3	0
2026-10-01	3	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

What could strengthen or challenge XPEL, Inc.’s outlook?

What the Thesis Depends On

Incoming Evidence

Expectations trend

Outlook in Brief

What's improving

Still unresolved / key risks

Next proof point

Historical risk context

XPEL, Inc. outlook in detail

What kind of bet this is

What's priced into XPEL, Inc.

What the fundamentals likely do

What XPEL, Inc. hinges on

Bottom line

Analyst view

Price-target changes

Bottom line